Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2005 4
2006 2
2007 3
2008 3
2009 1
2010 3
2011 4
2012 4
2013 7
2014 8
2015 11
2016 13
2017 16
2018 9
2019 13
2020 19
2021 14
2022 8
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial.
Schuler M, Cuppens K, Plönes T, Wiesweg M, Du Pont B, Hegedus B, Köster J, Mairinger F, Darwiche K, Paschen A, Maes B, Vanbockrijck M, Lähnemann D, Zhao F, Hautzel H, Theegarten D, Hartemink K, Reis H, Baas P, Schramm A, Aigner C. Schuler M, et al. Among authors: hegedus b. Nat Med. 2024 Apr 30. doi: 10.1038/s41591-024-02965-0. Online ahead of print. Nat Med. 2024. PMID: 38689060
Evolutionary trajectories of small cell lung cancer under therapy.
George J, Maas L, Abedpour N, Cartolano M, Kaiser L, Fischer RN, Scheel AH, Weber JP, Hellmich M, Bosco G, Volz C, Mueller C, Dahmen I, John F, Alves CP, Werr L, Panse JP, Kirschner M, Engel-Riedel W, Jürgens J, Stoelben E, Brockmann M, Grau S, Sebastian M, Stratmann JA, Kern J, Hummel HD, Hegedüs B, Schuler M, Plönes T, Aigner C, Elter T, Toepelt K, Ko YD, Kurz S, Grohé C, Serke M, Höpker K, Hagmeyer L, Doerr F, Hekmath K, Strapatsas J, Kambartel KO, Chakupurakal G, Busch A, Bauernfeind FG, Griesinger F, Luers A, Dirks W, Wiewrodt R, Luecke A, Rodermann E, Diel A, Hagen V, Severin K, Ullrich RT, Reinhardt HC, Quaas A, Bogus M, Courts C, Nürnberg P, Becker K, Achter V, Büttner R, Wolf J, Peifer M, Thomas RK. George J, et al. Among authors: hegedus b. Nature. 2024 Mar;627(8005):880-889. doi: 10.1038/s41586-024-07177-7. Epub 2024 Mar 13. Nature. 2024. PMID: 38480884 Free PMC article.
Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma.
Stockhammer P, Baumeister H, Ploenes T, Bonella F, Theegarten D, Dome B, Pirker C, Berger W, Hegedüs L, Baranyi M, Schuler M, Deshayes S, Bölükbas S, Aigner C, Blanquart C, Hegedüs B. Stockhammer P, et al. Among authors: hegedus b. Lung Cancer. 2023 Nov;185:107360. doi: 10.1016/j.lungcan.2023.107360. Epub 2023 Sep 7. Lung Cancer. 2023. PMID: 37713954 Free article.
Induction of metallothionein expression by supplementation of zinc induces resistance against platinum-based treatment in malignant pleural mesothelioma.
Wyrich M, Ohlig H, Wessolly M, Mairinger E, Steinborn J, Brcic L, Hegedus B, Hager T, Greimelmaier K, Wohlschlaeger J, Mairinger FD, Borchert S. Wyrich M, et al. Among authors: hegedus b. Transl Cancer Res. 2023 Aug 31;12(8):1929-1936. doi: 10.21037/tcr-22-2651. Epub 2023 Jul 21. Transl Cancer Res. 2023. PMID: 37701096 Free PMC article.
Early Detection of Lung Cancer Using Small RNAs.
Sikosek T, Horos R, Trudzinski F, Jehn J, Frank M, Rajakumar T, Klotz LV, Mercaldo N, Kahraman M, Heuvelman M, Taha Y, Gerwing J, Skottke J, Daniel-Moreno A, Sanchez-Delgado M, Bender S, Rudolf C, Hinkfoth F, Tikk K, Schenz J, Weigand MA, Feindt P, Schumann C, Christopoulos P, Winter H, Kreuter M, Schneider MA, Muley T, Walterspacher S, Schuler M, Darwiche K, Taube C, Hegedus B, Rabe KF, Rieger-Christ K, Jacobsen FL, Aigner C, Reck M, Bankier AA, Sharma A, Steinkraus BR. Sikosek T, et al. Among authors: hegedus b. J Thorac Oncol. 2023 Nov;18(11):1504-1523. doi: 10.1016/j.jtho.2023.07.005. Epub 2023 Jul 16. J Thorac Oncol. 2023. PMID: 37437883 Free article.
Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis.
Mosleh B, Schelch K, Mohr T, Klikovits T, Wagner C, Ratzinger L, Dong Y, Sinn K, Ries A, Berger W, Grasl-Kraupp B, Hoetzenecker K, Laszlo V, Dome B, Hegedus B, Jakopovic M, Hoda MA, Grusch M. Mosleh B, et al. Among authors: hegedus b. Thorac Cancer. 2023 Aug;14(22):2177-2186. doi: 10.1111/1759-7714.15004. Epub 2023 Jun 21. Thorac Cancer. 2023. PMID: 37340889 Free PMC article.
Laser ablation-inductively coupled plasma-mass spectrometry analysis reveals differences in chemotherapeutic drug distribution in surgically resected pleural mesothelioma.
Tisza A, Klikovits T, Benej M, Torok S, Szeitz B, Valko Z, Hoda MA, Hegedus B, Bonta M, Nischkauer W, Hoetzenecker K, Limbeck A, Schelch K, Laszlo V, Megyesfalvi Z, Dome B. Tisza A, et al. Among authors: hegedus b. Br J Clin Pharmacol. 2023 Nov;89(11):3364-3374. doi: 10.1111/bcp.15813. Epub 2023 Jul 14. Br J Clin Pharmacol. 2023. PMID: 37272312 Free PMC article.
One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-Radiotherapy.
Hager T, Borchert S, Wessolly M, Mathilakathu A, Mairinger E, Kollmeier J, Mairinger T, Hegedus B, Greimelmaier K, Wohlschlaeger J, Herrmann K, Mairinger FD. Hager T, et al. Among authors: hegedus b. Int J Mol Sci. 2023 Mar 28;24(7):6356. doi: 10.3390/ijms24076356. Int J Mol Sci. 2023. PMID: 37047331 Free PMC article.
143 results